These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 28859257)

  • 21. Single-center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients.
    Aryal S; Katugaha SB; Cochrane A; Brown AW; Nathan SD; Shlobin OA; Ahmad K; Marinak L; Chun J; Fregoso M; Desai S; King C
    Transpl Infect Dis; 2019 Dec; 21(6):e13166. PubMed ID: 31487755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients.
    Razonable RR
    Infect Dis Clin North Am; 2013 Jun; 27(2):317-42. PubMed ID: 23714343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of qualitative polymerase chain reaction combined with quantitation of viral load in the diagnosis and follow-up of cytomegalovirus infection after solid-organ transplantation.
    Vanpoucke H; Van Vlem B; Vanholder R; Van Renterghem L
    Intervirology; 1999; 42(5-6):398-404. PubMed ID: 10702723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and treatment of cytomegalovirus infection in organ transplant recipients.
    Kusne S; Shapiro R; Fung J
    Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A national survey of valganciclovir dosing strategies in pediatric organ transplant recipients.
    Shaikh S; Jasiak-Panek N; Park JM
    Clin Transplant; 2018 Sep; 32(9):e13369. PubMed ID: 30076649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of an ultrasensitive Cytomegalovirus quantitative nucleic acid test on Cytomegalovirus detection and therapy in renal transplant recipients.
    Beechar VB; Pouch SM; Phadke VK; Karadkhele G; Larsen CP; Woodworth MH
    Transpl Infect Dis; 2024 Feb; 26(1):e14219. PubMed ID: 38158932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.
    Haidar G; Boeckh M; Singh N
    J Infect Dis; 2020 Mar; 221(Suppl 1):S23-S31. PubMed ID: 32134486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection.
    Kalpoe JS; Kroes AC; de Jong MD; Schinkel J; de Brouwer CS; Beersma MF; Claas EC
    J Clin Microbiol; 2004 Apr; 42(4):1498-504. PubMed ID: 15070995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of cytomegalovirus: methodologic aspects and clinical applications.
    Boeckh M; Boivin G
    Clin Microbiol Rev; 1998 Jul; 11(3):533-54. PubMed ID: 9665982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.
    Sia IG; Patel R
    Clin Microbiol Rev; 2000 Jan; 13(1):83-121, table of contents. PubMed ID: 10627493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Special considerations in the management of cytomegalovirus infection in pediatric solid organ transplant recipients].
    Rumbao J; Frauca E
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 6():70-3. PubMed ID: 22541928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cytomegalovirus: a survey of end-organ diseases and diagnostic challenges in solid organ transplant recipients.
    Contreras G; Ho D
    Curr Opin Organ Transplant; 2022 Aug; 27(4):243-249. PubMed ID: 36354249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients.
    Flexman J; Kay I; Fonte R; Herrmann R; Gabbay E; Palladino S
    J Med Virol; 2001 Jul; 64(3):275-82. PubMed ID: 11424115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
    Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
    Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection.
    Benmarzouk-Hidalgo OJ; Cordero E; Martín-Peña A; García-Prado E; Gentil MA; Gomez-Bravo MA; Barrera-Pulido L; Cisneros JM; Perez-Romero P
    Antivir Ther; 2009; 14(5):641-7. PubMed ID: 19704166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.
    Gimeno C; Solano C; Latorre JC; Hernández-Boluda JC; Clari MA; Remigia MJ; Furió S; Calabuig M; Tormo N; Navarro D
    J Clin Microbiol; 2008 Oct; 46(10):3311-8. PubMed ID: 18753357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CMV infection management in transplant patients in Italy.
    Grossi PA; Baldanti F; Andreoni M; Perno CF
    J Clin Virol; 2020 Feb; 123():104211. PubMed ID: 31879243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.
    Hebart H; Kanz L; Jahn G; Einsele H
    Drugs; 1998 Jan; 55(1):59-72. PubMed ID: 9463790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of cytomegalovirus infection in solid organ transplantation.
    Kotton CN
    Nat Rev Nephrol; 2010 Dec; 6(12):711-21. PubMed ID: 20978468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.